Corcept Director Holds Million Shares Through Rebound
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
This comparison highlights which option tends to exhibit higher or lower risk in retirement contexts, with practical takeaways.
24,440 articlesImagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
As of mid-February 2026, state regulators hold a steady advantage in the legal battle over prediction markets, even w...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...
When a stock beats estimates but slides after hours, it creates a nagging question for investors. Here’s a clear, pra...
Apple is reportedly adopting a Netflix style strategy, focusing on originals, bundling, and scalable growth. This art...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
A court filing reveals JPMorgan Chase closed Donald Trump’s accounts after the Jan. 6 attack, marking a major turn in...
Backpack is launching a year-long staking program that could convert a portion of its tokens into a 20% equity stake ...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Tech giants push AI-led gains as the Nasdaq plays catch-up, with policy updates and earnings previews guiding a cauti...